12 research outputs found
Making effective use of healthcare data using data-to-text technology
Healthcare organizations are in a continuous effort to improve health
outcomes, reduce costs and enhance patient experience of care. Data is
essential to measure and help achieving these improvements in healthcare
delivery. Consequently, a data influx from various clinical, financial and
operational sources is now overtaking healthcare organizations and their
patients. The effective use of this data, however, is a major challenge.
Clearly, text is an important medium to make data accessible. Financial reports
are produced to assess healthcare organizations on some key performance
indicators to steer their healthcare delivery. Similarly, at a clinical level,
data on patient status is conveyed by means of textual descriptions to
facilitate patient review, shift handover and care transitions. Likewise,
patients are informed about data on their health status and treatments via
text, in the form of reports or via ehealth platforms by their doctors.
Unfortunately, such text is the outcome of a highly labour-intensive process if
it is done by healthcare professionals. It is also prone to incompleteness,
subjectivity and hard to scale up to different domains, wider audiences and
varying communication purposes. Data-to-text is a recent breakthrough
technology in artificial intelligence which automatically generates natural
language in the form of text or speech from data. This chapter provides a
survey of data-to-text technology, with a focus on how it can be deployed in a
healthcare setting. It will (1) give an up-to-date synthesis of data-to-text
approaches, (2) give a categorized overview of use cases in healthcare, (3)
seek to make a strong case for evaluating and implementing data-to-text in a
healthcare setting, and (4) highlight recent research challenges.Comment: 27 pages, 2 figures, book chapte
Action Potentials of HL-1 Cells Recorded With Silicon Nanowire Transistors
Silicon nanowire (NW) transistors were fabricated in a top-down process. These devices were used to record the extracellular potential of the spontaneous activity of cardiac muscle HL-1 cells. Their signals were measured by direct dc sampling of the drain current. An improved signal-to-noise ratio compared to planar field-effect devices was observed. Furthermore the signal shape was evaluated and could be associated to different membrane currents. With these experiments, a qualitative description of the properties of the cell-NW contact was obtained and the suitability of these sensors for electrophysiological measurements in vitro was demonstrated
Maximizing the clinical benefit of radiotherapy in solitary plasmacytoma: An international multicenter analysis
International audienceObjective: Although local definitive radiotherapy (RT) is considered the standard of care for solitary plasmacytoma (SP), the optimal RT parameters for SP patients have not been defined. The aim of this retrospective study is to analyze the effectiveness of various RT doses, volumes, and techniques, as well as to define the relevant prognostic factors in SP. Methods: Between 2000 and 2019, 84 patients, including 54 with solitary bone plasmacytoma (SBP) and 30 with extramedullary plasmacytoma (EMP), underwent RT at six institutions. Results: The overall RT median dose was 42 Gy (range, 36.0–59.4). The median follow-up period was 46 months. Overall, the local control (LC) rate was 96%, while the complete remission (CR) rate was 46%. The 5-year local relapse-free survival (LRFS), multiple myeloma-free survival (MMFS), progression-free survival (PFS), and overall survival (OS) rates were 89%, 71%, 55%, and 93%, respectively. Using an RT dose above 40 Gy was associated with a higher complete remission (CR) rate and a lower rate of local relapse. Modern irradiation techniques were associated with a trend toward a higher LC rate (98% vs. 87% for conventional, p = 0.09) and a significantly lower local relapse rate (6% vs. 25% for conventional, p = 0.04). However, RT dose escalation and technique did not lead to a significant effect on MMFS, PFS, and OS. Univariate analyses identified several patient characteristics as potentially relevant prognostic factors. In SBP patients, systemic therapy administration was associated significantly with MMFS and PFS rates. Conclusion: Using an RT dose >40 Gy and modern RT techniques may improve the local control and reduce the rate of relapse, without a significant impact on survival rates. The addition of systemic therapies may improve the MMFS and PFS rates of SBP patients
Maximizing the Clinical Benefit of Radiotherapy in Solitary Plasmacytoma: An International Multicenter Analysis
Objective: Although local definitive radiotherapy (RT) is considered the standard of care for solitary plasmacytoma (SP), the optimal RT parameters for SP patients have not been defined. The aim of this retrospective study is to analyze the effectiveness of various RT doses, volumes, and techniques, as well as to define the relevant prognostic factors in SP. Methods: Between 2000 and 2019, 84 patients, including 54 with solitary bone plasmacytoma (SBP) and 30 with extramedullary plasmacytoma (EMP), underwent RT at six institutions. Results: The overall RT median dose was 42 Gy (range, 36.0–59.4). The median follow-up period was 46 months. Overall, the local control (LC) rate was 96%, while the complete remission (CR) rate was 46%. The 5-year local relapse-free survival (LRFS), multiple myeloma-free survival (MMFS), progression-free survival (PFS), and overall survival (OS) rates were 89%, 71%, 55%, and 93%, respectively. Using an RT dose above 40 Gy was associated with a higher complete remission (CR) rate and a lower rate of local relapse. Modern irradiation techniques were associated with a trend toward a higher LC rate (98% vs. 87% for conventional, p = 0.09) and a significantly lower local relapse rate (6% vs. 25% for conventional, p = 0.04). However, RT dose escalation and technique did not lead to a significant effect on MMFS, PFS, and OS. Univariate analyses identified several patient characteristics as potentially relevant prognostic factors. In SBP patients, systemic therapy administration was associated significantly with MMFS and PFS rates. Conclusion: Using an RT dose >40 Gy and modern RT techniques may improve the local control and reduce the rate of relapse, without a significant impact on survival rates. The addition of systemic therapies may improve the MMFS and PFS rates of SBP patients